{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T03:55:41Z","timestamp":1783828541362,"version":"3.55.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2507,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/labinvest.2015.135","type":"journal-article","created":{"date-parts":[[2015,11,16]],"date-time":"2015-11-16T08:41:48Z","timestamp":1447663308000},"page":"283-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Diabetes enhances the efficacy of AAV2 vectors in the retina: therapeutic effect of AAV2 encoding vasoinhibin and soluble VEGF receptor 1"],"prefix":"10.1016","volume":"96","author":[{"given":"Nundehui","family":"D\u00edaz-Lezama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elva","family":"Ad\u00e1n-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"V\u00e1zquez-Membrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Arredondo-Zamarripa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G","family":"Ledesma-Colunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibiana","family":"Moreno-Carranza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Martinez de la Escalera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Colosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Clapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2015.135_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/2042018813512360","article-title":"Anti-vascular endothelial growth factor therapy for diabetic macular edema","volume":"4","author":"Boyer","year":"2013","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1038\/labinvest.2015.135_bib2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/gt.2011.151","article-title":"Novel adeno-associated viral vectors for retinal gene therapy","volume":"19","author":"Vandenberghe","year":"2012","journal-title":"Gene Ther"},{"key":"10.1038\/labinvest.2015.135_bib3","doi-asserted-by":"crossref","first-page":"8944","DOI":"10.1167\/iovs.11-8190","article-title":"Vasoinhibin gene transfer by adenoassociated virus type 2 protects against Vegf- and diabetes-induced retinal vasopermeability","volume":"52","author":"Ramirez","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/labinvest.2015.135_bib4","first-page":"133","article-title":"Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector","volume":"13","author":"Shyong","year":"2007","journal-title":"Mol Vis"},{"key":"10.1038\/labinvest.2015.135_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/mt.2011.155","article-title":"Ace2 and Ang-(1-7) confer protection against development of diabetic retinopathy","volume":"20","author":"Verma","year":"2012","journal-title":"Mol Ther"},{"key":"10.1038\/labinvest.2015.135_bib6","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood-2003-02-0495","article-title":"Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy","volume":"102","author":"Grimm","year":"2003","journal-title":"Blood"},{"key":"10.1038\/labinvest.2015.135_bib7","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1167\/iovs.05-0173","article-title":"Prolactins are natural inhibitors of angiogenesis in the retina","volume":"46","author":"Aranda","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/labinvest.2015.135_bib8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1038\/labinvest.2015.135_bib9","first-page":"789","article-title":"Sensitive blood-retinal barrier breakdown quantitation using evans blue","volume":"42","author":"Xu","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/labinvest.2015.135_bib10","doi-asserted-by":"crossref","first-page":"e27385","DOI":"10.1371\/journal.pone.0027385","article-title":"A Computational tool for quantitative analysis of vascular networks","volume":"6","author":"Zudaire","year":"2011","journal-title":"PLoS One"},{"key":"10.1038\/labinvest.2015.135_bib11","doi-asserted-by":"crossref","first-page":"12868","DOI":"10.3390\/molecules171112868","article-title":"Hesperidin prevents retinal and plasma abnormalities in streptozotocin-induced diabetic rats","volume":"17","author":"Shi","year":"2012","journal-title":"Molecules"},{"key":"10.1038\/labinvest.2015.135_bib12","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1167\/iovs.07-0721","article-title":"Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes","volume":"49","author":"Zhang","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/labinvest.2015.135_bib13","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1167\/iovs.08-3293","article-title":"Inhibition of vitreoretinal vegf elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine","volume":"51","author":"Kusari","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/labinvest.2015.135_bib14","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.2337\/db10-0873","article-title":"High levels of serum prolactin protect against diabetic retinopathy by increasing ocular vasoinhibins","volume":"59","author":"Arnold","year":"2010","journal-title":"Diabetes"},{"key":"10.1038\/labinvest.2015.135_bib15","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.2337\/db10-1260","article-title":"Plasma kallikrein mediates retinal vascular dysfunction and induces retinal thickening in diabetic rats","volume":"60","author":"Clermont","year":"2011","journal-title":"Diabetes"},{"key":"10.1038\/labinvest.2015.135_bib16","first-page":"2121","article-title":"Validation of structural and functional lesions of diabetic retinopathy in mice","volume":"16","author":"Kern","year":"2010","journal-title":"Mol Vis"},{"key":"10.1038\/labinvest.2015.135_bib17","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1167\/iovs.02-0738","article-title":"Structural and hemodynamic analysis of the mouse retinal microcirculation","volume":"44","author":"Paques","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/labinvest.2015.135_bib18","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/mt.2008.103","article-title":"Recombinant adeno-associated virus transduction and integration","volume":"16","author":"Schultz","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/labinvest.2015.135_bib19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.tim.2008.01.012","article-title":"The parvovirus capsid odyssey: from the cell surface to the nucleus","volume":"16","author":"Harbison","year":"2008","journal-title":"Trends Microbiol"},{"key":"10.1038\/labinvest.2015.135_bib20","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1128\/JVI.72.2.1438-1445.1998","article-title":"Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions","volume":"72","author":"Summerford","year":"1998","journal-title":"J Virol"},{"key":"10.1038\/labinvest.2015.135_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/4758","article-title":"Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2","volume":"5","author":"Qing","year":"1999","journal-title":"Nat Med"},{"key":"10.1038\/labinvest.2015.135_bib22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/4768","article-title":"Alphavbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection","volume":"5","author":"Summerford","year":"1999","journal-title":"Nat Med"},{"key":"10.1038\/labinvest.2015.135_bib23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1128\/JVI.79.1.609-614.2005","article-title":"Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection","volume":"79","author":"Kashiwakura","year":"2005","journal-title":"J Virol"},{"key":"10.1038\/labinvest.2015.135_bib24","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1038\/labinvest.2015.135_bib25","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ophtha.2005.10.030","article-title":"Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema","volume":"113","author":"Funatsu","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1038\/labinvest.2015.135_bib26","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s11892-014-0510-4","article-title":"Anti-Vegf therapy for diabetic macular edema","volume":"14","author":"Stewart","year":"2014","journal-title":"Curr Diab Rep"},{"key":"10.1038\/labinvest.2015.135_bib27","doi-asserted-by":"crossref","first-page":"632307","DOI":"10.1155\/2014\/632307","article-title":"Anti-Vegf for the management of diabetic macular edema","volume":"2014","author":"Stefanini","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1038\/labinvest.2015.135_bib28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10456-006-9055-8","article-title":"Vascular endothelial growth factor receptor-1 (Vegfr-1\/Flt-1): a dual regulator for angiogenesis","volume":"9","author":"Shibuya","year":"2006","journal-title":"Angiogenesis"},{"key":"10.1038\/labinvest.2015.135_bib29","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1152\/physrev.00024.2009","article-title":"Peptide hormone regulation of angiogenesis","volume":"89","author":"Clapp","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1038\/labinvest.2015.135_bib30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1530\/EJE-09-0130","article-title":"Investigation of prolactin-related vasoinhibin in sera from patients with diabetic retinopathy","volume":"161","author":"Triebel","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/labinvest.2015.135_bib31","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1167\/iovs.03-1001","article-title":"Molecular targeting of antiangiogenic factor 16k Hprl inhibits oxygen-induced retinopathy in mice","volume":"45","author":"Pan","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/labinvest.2015.135_bib32","first-page":"2291","article-title":"Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2a-dependent Enos inactivation","volume":"118","author":"Garcia","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2015.135_bib33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3389\/fncel.2014.00333","article-title":"Vasoinhibins regulate the inner and outer blood-retinal barrier and limit retinal oxidative stress","volume":"8","author":"Arredondo Zamarripa","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"10.1038\/labinvest.2015.135_bib34","first-page":"75","article-title":"Prevention of diabetic retinopathy by intraocular soluble Flt-1 gene transfer in a spontaneously diabetic rat model","volume":"19","author":"Ideno","year":"2007","journal-title":"Int J Mol Med"},{"key":"10.1038\/labinvest.2015.135_bib35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/104303403321070829","article-title":"Periocular gene transfer of sflt-1 suppresses ocular neovascularization and vascular endothelial growth factor-induced breakdown of the blood-retinal barrier","volume":"14","author":"Gehlbach","year":"2003","journal-title":"Hum Gene Ther"},{"key":"10.1038\/labinvest.2015.135_bib36","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/cvr\/cvq105","article-title":"Vascular endothelial growth factors and vascular permeability","volume":"87","author":"Bates","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1038\/labinvest.2015.135_bib37","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.1210\/en.2004-0647","article-title":"16k-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation","volume":"145","author":"Gonzalez","year":"2004","journal-title":"Endocrinology"},{"key":"10.1038\/labinvest.2015.135_bib38","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3390\/ph4071052","article-title":"Vasoinhibins prevent bradykinin-stimulated endothelial cell proliferation by inactivating Enos via reduction of both intracellular Ca2+ levels and enos phosphorylation at Ser1179","volume":"4","author":"Thebault","year":"2011","journal-title":"Pharmaceuticals"},{"key":"10.1038\/labinvest.2015.135_bib39","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1167\/iovs.05-0272","article-title":"Retinal thickness and subnormal retinal oxygenation response in experimental diabetic retinopathy","volume":"47","author":"Luan","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/labinvest.2015.135_bib40","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1167\/iovs.09-4727","article-title":"Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats","volume":"52","author":"Zhang","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/labinvest.2015.135_bib41","first-page":"181","article-title":"Attenuation of diabetic retinopathy by enhanced inhibition of Mmp-2 and Mmp-9 using aspirin and minocycline in streptozotocin-diabetic rats","volume":"2","author":"Bhatt","year":"2010","journal-title":"Am J Transl Res"},{"key":"10.1038\/labinvest.2015.135_bib42","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/bjo.2006.111534","article-title":"Decreased optical coherence tomography-measured pericentral retinal thickness in patients with diabetes mellitus Type 1 with minimal diabetic retinopathy","volume":"91","author":"Biallosterski","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1038\/labinvest.2015.135_bib43","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1167\/iovs.08-3143","article-title":"Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy","volume":"50","author":"van Dijk","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/labinvest.2015.135_bib44","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/eye.2008.119","article-title":"Changes of macular and Rnfl thicknesses measured by stratus Oct in patients with early stage diabetes","volume":"23","author":"Oshitari","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1038\/labinvest.2015.135_bib45","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1167\/iovs.09-5041","article-title":"Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes","volume":"51","author":"van Dijk","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/labinvest.2015.135_bib46","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI2425","article-title":"Neural apoptosis in the retina during experimental and human diabetes. early onset and effect of insulin","volume":"102","author":"Barber","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2015.135_bib47","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s00125-003-1177-6","article-title":"Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina","volume":"46","author":"Park","year":"2003","journal-title":"Diabetologia"},{"key":"10.1038\/labinvest.2015.135_bib48","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1167\/iovs.07-0433","article-title":"Impaired apparent ion demand in experimental diabetic retinopathy: correction by lipoic acid","volume":"48","author":"Berkowitz","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/labinvest.2015.135_bib49","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1167\/iovs.04-0247","article-title":"Death of retinal neurons in streptozotocin-induced diabetic mice","volume":"45","author":"Martin","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/labinvest.2015.135_bib50","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1167\/iovs.04-1361","article-title":"Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes","volume":"46","author":"Feit-Leichman","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/labinvest.2015.135_bib51","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/mt.2010.258","article-title":"Preclinical safety evaluation of Aav2-Sflt01- a gene therapy for age-related macular degeneration","volume":"19","author":"Maclachlan","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/labinvest.2015.135_bib52","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/mt.2010.230","article-title":"Inhibition of choroidal neovascularization in a nonhuman primate model by intravitreal administration of an Aav2 vector expressing a novel Anti-Vegf molecule","volume":"19","author":"Lukason","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/labinvest.2015.135_bib53","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/hmg\/10.26.3075","article-title":"Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model","volume":"10","author":"Auricchio","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1038\/labinvest.2015.135_bib54","doi-asserted-by":"crossref","first-page":"11072","DOI":"10.1128\/JVI.77.20.11072-11081.2003","article-title":"Identification of a heparin-binding motif on adeno-associated virus type 2 capsids","volume":"77","author":"Kern","year":"2003","journal-title":"J Virol"},{"key":"10.1038\/labinvest.2015.135_bib55","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/156652306775515565","article-title":"Heparan sulphate proteoglycans and viral vectors: ally or foe?","volume":"6","author":"Vives","year":"2006","journal-title":"Curr Gene Ther"},{"key":"10.1038\/labinvest.2015.135_bib56","first-page":"568","article-title":"Rapid upregulation of fibroblast growth factor receptor 1 (Flg) by rat photoreceptor cells after injury","volume":"41","author":"Ozaki","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/labinvest.2015.135_bib57","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1091\/mbc.9.10.2785","article-title":"Fibroblast growth factor (Fgf) soluble receptor 1 acts as a natural inhibitor of Fgf2 neurotrophic activity during retinal degeneration","volume":"9","author":"Guillonneau","year":"1998","journal-title":"Mol Biol Cell"},{"key":"10.1038\/labinvest.2015.135_bib58","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/mvre.1994.1048","article-title":"Cell-associated proteoglycans of retinal pericytes and endothelial cells: modulation by glucose and ascorbic acid","volume":"48","author":"Fisher","year":"1994","journal-title":"Microvasc Res"},{"key":"10.1038\/labinvest.2015.135_bib59","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1475-2840-8-46","article-title":"Changes in cultured endothelial cell glycosaminoglycans under hyperglycemic conditions and the effect of insulin and heparin","volume":"8","author":"Han","year":"2009","journal-title":"Cardiovasc Diabetol"},{"key":"10.1038\/labinvest.2015.135_bib60","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1076\/ceyr.22.3.190.5519","article-title":"Vascular localization of heparan sulfate proteoglycans in retinas of patients with diabetes mellitus and in vegf-induced retinopathy using domain-specific antibodies","volume":"22","author":"Witmer","year":"2001","journal-title":"Curr Eye Res"},{"key":"10.1038\/labinvest.2015.135_bib61","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1242\/dev.122.11.3443","article-title":"A proteoglycan that activates fibroblast growth factors during early neuronal development is a perlecan variant","volume":"122","author":"Joseph","year":"1996","journal-title":"Development"},{"key":"10.1038\/labinvest.2015.135_bib62","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.abb.2007.10.006","article-title":"The core protein of growth plate perlecan binds Fgf-18 and alters its mitogenic effect on chondrocytes","volume":"468","author":"Smith","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"10.1038\/labinvest.2015.135_bib63","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/archopht.1991.01080070117048","article-title":"Altered distribution of basic fibroblast growth factor in diabetic retinopathy","volume":"109","author":"Hanneken","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1038\/labinvest.2015.135_bib64","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/dmrr.236","article-title":"Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complications","volume":"17","author":"Conde-Knape","year":"2001","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1038\/labinvest.2015.135_bib65","doi-asserted-by":"crossref","first-page":"9764","DOI":"10.1073\/pnas.93.18.9764","article-title":"Involvement of integrins alpha V Beta 3 and alpha V beta 5 in ocular neovascular diseases","volume":"93","author":"Friedlander","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.2015.135_bib66","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1076\/ceyr.16.2.127.5089","article-title":"Heparan sulfate proteoglycan synthesis and its expression are decreased in the retina of diabetic rats","volume":"16","author":"Bollineni","year":"1997","journal-title":"Curr Eye Res"},{"key":"10.1038\/labinvest.2015.135_bib67","first-page":"325","article-title":"Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina","volume":"75","author":"Hammes","year":"1996","journal-title":"Lab Invest"},{"key":"10.1038\/labinvest.2015.135_bib68","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1743-422X-4-99","article-title":"The state of the art of adeno-associated virus-based vectors in gene therapy","volume":"4","author":"Coura Rdos","year":"2007","journal-title":"Virol J"},{"key":"10.1038\/labinvest.2015.135_bib69","doi-asserted-by":"crossref","first-page":"10371","DOI":"10.1128\/JVI.73.12.10371-10376.1999","article-title":"Dynamin is required for recombinant adeno-associated virus type 2 infection","volume":"73","author":"Duan","year":"1999","journal-title":"J Virol"},{"key":"10.1038\/labinvest.2015.135_bib70","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1172\/JCI8317","article-title":"Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus","volume":"105","author":"Duan","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2015.135_bib71","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.2337\/db05-1635","article-title":"Diabetic retinopathy: seeing beyond glucose-induced microvascular disease","volume":"55","author":"Antonetti","year":"2006","journal-title":"Diabetes"},{"key":"10.1038\/labinvest.2015.135_bib72","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/hum.2009.194","article-title":"Changes in adeno-associated virus-mediated gene delivery in retinal degeneration","volume":"21","author":"Kolstad","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1038\/labinvest.2015.135_bib73","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/glia.22617","article-title":"AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers","volume":"62","author":"Vacca","year":"2014","journal-title":"Glia"},{"key":"10.1038\/labinvest.2015.135_bib74","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/hgtb.2013.089","article-title":"Laser photocoagulation enhances adeno-associated viral vector transduction of mouse retina","volume":"25","author":"Lee","year":"2014","journal-title":"Hum Gene Ther Methods"},{"key":"10.1038\/labinvest.2015.135_bib75","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.gt.3302527","article-title":"Intracellular trafficking of adeno-associated viral vectors","volume":"12","author":"Ding","year":"2005","journal-title":"Gene Ther"},{"key":"10.1038\/labinvest.2015.135_bib76","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/sj.gt.3302585","article-title":"Gene therapy progress and prospects: viral trafficking during infection","volume":"12","author":"Campbell","year":"2005","journal-title":"Gene Ther"},{"key":"10.1038\/labinvest.2015.135_bib77","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1128\/jvi.70.5.3227-3234.1996","article-title":"Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors","volume":"70","author":"Ferrari","year":"1996","journal-title":"J Virol"},{"key":"10.1038\/labinvest.2015.135_bib78","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1128\/JVI.78.6.3110-3122.2004","article-title":"Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors","volume":"78","author":"Thomas","year":"2004","journal-title":"J Virol"},{"key":"10.1038\/labinvest.2015.135_bib79","doi-asserted-by":"crossref","unstructured":"Joussen Antonia M., Gardner Thomas W., Kirchhof Bernd, Ryan Stephen J., Retinal Vascular Disease, 2007, Berlin, Heidelberg, Springer Berlin Heidelberg.","DOI":"10.1007\/978-3-540-29542-6"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest2015135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest2015135","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722014106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722014106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest2015135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:41:02Z","timestamp":1758397262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722014106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0023683722014106"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2015.135","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes enhances the efficacy of AAV2 vectors in the retina: therapeutic effect of AAV2 encoding vasoinhibin and soluble VEGF receptor 1","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2015.135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}